1 Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic School of Medicine, Rochester, Minnesota, USA.
2 Department of Neurologic Surgery, Mayo Clinic School of Medicine, Rochester, Minnesota, USA.
Otolaryngol Head Neck Surg. 2018 Sep;159(3):535-542. doi: 10.1177/0194599818770413. Epub 2018 Apr 24.
Objective (1) Assess 3-dimensional volumetric growth of untreated sporadic vestibular schwannomas (VSs) in a large cohort of patients treated with conservative observation. (2) Compare volumetric and conventional linear diameter measurements for detecting tumor growth. Study Design Case series with chart review. Setting Tertiary skull base referral center. Subjects and Methods Patients with sporadic VS who elected initial conservative treatment with at least 2 serial magnetic resonance imaging (MRI) scans were included. Tumor volume was determined with 3-dimensional segmentation of MRI sequences. The volumetric threshold for tumor growth was an increase ≥20% from baseline tumor volume. Tumor size based on linear diameter was assessed with the 1995 American Academy of Otolaryngology-Head and Neck Surgery Foundation guidelines for VS outcome reporting, with growth defined as an increase ≥2 mm. Results A total of 361 patients were included with a median radiologic follow-up of 4.1 years (interquartile range [IQR], 2.5-6.8). At diagnosis, 232 VSs (64%) were purely intracanalicular, and 129 (36%) extended into the cerebellopontine angle. The median baseline tumor volume was 0.161 cm (IQR, 0.054-0.418). Overall, 69% of tumors demonstrated volumetric growth at a median of 1.1 years (IQR, 0.6-2.1) after initial MRI. In contrast, based on linear measurement assessment, 48% of tumors demonstrated growth at a median of 1.8 years (IQR, 0.8-3.1) from first MRI scan. Disequilibrium, facial hypoesthesia, aural fullness, initial tumor size, and nonincidental diagnosis were associated with tumor growth. Conclusion Three-dimensional volumetric assessment of VS provides a more sensitive measure of tumor growth when compared with linear diameter assessment. Through volumetric analysis, the current study revealed that a significant proportion of VSs demonstrate growth during observation.
(1)评估大量接受保守观察治疗的散发性前庭神经鞘瘤(VS)患者未经治疗的 3 维体积生长情况。(2)比较体积和传统线性直径测量在检测肿瘤生长中的作用。
病例系列,病历回顾。
三级颅底转诊中心。
纳入选择初始保守治疗且至少有 2 次连续磁共振成像(MRI)扫描的散发性 VS 患者。通过 MRI 序列的 3 维分割确定肿瘤体积。肿瘤生长的体积阈值为与基线肿瘤体积相比增加≥20%。根据线性直径评估肿瘤大小,采用 1995 年美国耳鼻喉科学-头颈外科学基金会(American Academy of Otolaryngology-Head and Neck Surgery Foundation)VS 结果报告指南,生长定义为增加≥2mm。
共纳入 361 例患者,中位影像学随访时间为 4.1 年(四分位距[IQR],2.5-6.8)。诊断时,232 个 VS(64%)位于单纯内听道,129 个(36%)延伸至桥小脑角。中位基线肿瘤体积为 0.161cm(IQR,0.054-0.418)。总体而言,69%的肿瘤在初始 MRI 后 1.1 年(IQR,0.6-2.1)时出现体积生长。相比之下,根据线性测量评估,48%的肿瘤在首次 MRI 扫描后 1.8 年(IQR,0.8-3.1)时出现生长。平衡障碍、面部感觉减退、耳部饱满感、初始肿瘤大小和非偶然诊断与肿瘤生长相关。
与线性直径评估相比,VS 的 3 维体积评估提供了更敏感的肿瘤生长测量方法。通过体积分析,本研究显示,相当一部分 VS 在观察期间会出现生长。